Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- A New Index Of Emerging Biotech And Pharma Companies
Nov 22, 2008 08:25 PM
- Post Fed Earnings
Aug 06, 2008 10:38 AM
- Periodicals Wrap-Up for Thursday, July 11th
Jul 11, 2008 09:32 AM
- Biotech Exhibiting a Quiet Strength
Jun 25, 2008 10:14 PM
- Play The Oversold Bounce
Jun 12, 2008 10:30 AM
- Stay Confident About Biotech
Jun 12, 2008 01:20 AM
- Analyst Comments: Pepsi Bottling, Mitsubishi Financial, Potash Corp, BioMarin, CACI International, Charles Schwab, Peets Coffee
Jun 11, 2008 10:51 AM
- Biotech Continues to Outperform
May 30, 2008 01:34 AM
- Big Green Day!
May 02, 2008 01:59 AM
- Analyst Comments: BioMarin, ViroPharma, Shanghai Petro, Lexicon Pharmaceuticals
May 01, 2008 02:38 AM
- BioMarin to Present at the Piper Jaffray Healthcare Conference
Nov 25, 2008 09:01 AM
- BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer
Nov 21, 2008 04:30 PM
- Data to Be Presented at 58th Annual Meeting of The American Society of Human Genetics
Nov 06, 2008 09:01 AM
- BioMarin to Present at the Credit Suisse Healthcare Conference
Nov 05, 2008 09:01 AM
- BioMarin Announces Initiation of Clinical Assessment Program for Morquio A Syndrome
Nov 03, 2008 09:03 AM
- BioMarin Announces Third Quarter 2008 Financial Results
Oct 28, 2008 04:00 PM
- BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
Oct 15, 2008 04:00 PM
- BioMarin to Host Third Quarter 2008 Financial Results Conference Call and Webcast on Tuesday, October 28 at 5:00 p.m. ET (23:00 CET)
Oct 07, 2008 09:01 AM
- BioMarin Opens Office in Brisbane to Support Expanding Operations
Oct 07, 2008 09:01 AM
- Kuvan Receives Positive Opinion From CHMP for European Approval
Sep 25, 2008 04:05 PM
- Form 4 KAKKIS EMIL D For: Nov 25 (10K)
Nov 25, 2008 08:30 PM
- Form 4 BIOMARIN PHARMACEUTICAL For: Oct 31 Filed by: KAKKIS EMIL D (10K)
Nov 05, 2008 02:54 PM
- Form 4 Wood Mark For: Oct 21 (10K)
Oct 23, 2008 07:38 PM
- Form 4 KAKKIS EMIL D For: Oct 01 (10K)
Oct 03, 2008 08:23 PM
- Form 4 BIOMARIN PHARMACEUTICAL For: Sep 22 Filed by: Wood Mark (10K)
Sep 24, 2008 03:21 PM
- Form 4 BIOMARIN PHARMACEUTICAL For: Sep 02 Filed by: BAFFI ROBERT (10K)
Sep 04, 2008 09:14 PM
- Form 4 BIOMARIN PHARMACEUTICAL For: Sep 02 Filed by: KAKKIS EMIL D (10K)
Sep 03, 2008 09:16 PM
- Form 4 Wood Mark For: Aug 21 (10K)
Aug 25, 2008 07:16 PM
- Form 4 BIOMARIN PHARMACEUTICAL For: Aug 08 Filed by: BIENAIME JEAN JACQUES (10K)
Aug 12, 2008 09:08 PM
- Form 4 BAFFI ROBERT For: Jul 30 (10K)
Jul 31, 2008 06:43 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
BMRN
|
Compare to S&P
|
| YTD |
-51.89 %
|
-21.18 %
|
| 4 Weeks |
-7.04 %
|
0.48 %
|
| 12 Weeks |
-38.83 %
|
-15.21 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -75.00 %
|
|
EPS Growth in Last Year: 120.00 %
|
|
Sales Growth in Last Quarter: 13.20 %
|
|
Sales Growth in Last Quarter: 190.51 %
|
|
|
